BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Nimbus Discovery 

25 First Street
Suite 303
Cambridge  Massachusetts  02141  U.S.A.
Phone: 617-588-2600 Fax: 617-231-0652


SEARCH JOBS





Segment
Pharmaceuticals





 Company News
Nimbus Discovery To Present Data Showing That Selective ACC Inhibitors Dramatically Impact Tumor Growth In Pre-Clinical Models At American Association for Cancer Research Annual Meeting 2014 4/2/2014 9:37:38 AM
Nimbus Discovery IRAK4 Inhibitor Demonstrates Synergistic Effects In Preclinical Studies With Three Kinase Inhibitors For The Treatment Of Lymphoid Malignancies 12/9/2013 9:52:55 AM
Nimbus Discovery Advances Broad Portfolio of ACC Inhibitors for Potential Treatment of Diabetes, NASH and Liver Cancer 11/1/2013 9:55:29 AM
Nimbus Discovery and Monsanto Company (MON) Announce Collaboration 6/27/2013 9:58:56 AM
Nimbus Discovery Presents Compelling Preclinical Proof of Concept Data on Novel ACC Allosteric Inhibitor ND-630 6/24/2013 11:23:29 AM
Nimbus Discovery Announces Agreement With Shire plc to Co-Develop Therapies for Rare Diseases 5/8/2013 10:58:44 AM
Nimbus Discovery Appoints William F. Westlin, Ph.D., as Head of Preclinical Research and Early Development 2/6/2013 9:31:28 AM
Nimbus Discovery IRAK4 Inhibitors Demonstrate Synergistic Effects With BTK Inhibitor Ibrutinib 12/10/2012 10:02:01 AM
Nimbus Discovery Presents Preclinical Data on Highly Selective IRAK4 Inhibitors for the Treatment of Rheumatic Diseases 11/12/2012 10:02:00 AM
Nimbus Discovery and Proteros biostructures GmbH Enter into Privileged X-Ray Crystallography Partnership Agreement 11/8/2012 10:26:19 AM
12